Welcome to China SXT Pharmaceuticals, Inc. Official Website!
Hotline:
+86-523-86299087
Email:
ir@sxtchina.com
NASDAQ:
SXTC
Contact Us
Toggle navigation
HOME
ABOUT
COMPANY
TEAM
COMPANY STRUCTURE
COMPANY AWARDS
CONTACT
BRAND
BRAND HISTORY
R&D
RESEARCH AND DEVELOPMENT
R&D STRATEGY
INTELLECTUAL PROPERTY RIGHT
MEDIA
LATEST NEWS
COMPANY NEWS
INVESTORS
STOCK INFO
SEC FILINGS
FINANCIALS
PRESS
SHAREHOLDER SERVICES
PUBLIC POLICIES
POLICIES
GUIDELINES
X
HOME
ABOUT
COMPANY
TEAM
COMPANY STRUCTURE
COMPANY AWARDS
CONTACT
BRAND
BRAND HISTORY
R&D TEAM
RESEARCH AND DEVELOPMENT
R&D STRATEGY
INTELLECTUAL PROPERTY RIGHT
PRODUCT
DIRECTLY-ORAL TCMP
AFTER-SOAKING-ORAL TCMP
FINE TCMP
REGULAR TCMP
MEDIA
LATEST NEWS
COMPANY NES
INVESTORS
STOCK INFO
SEC FILINGS
FINANCIALS
PRESS
SHAREHOLDER SERVICES
PUBLIC POLICIES
POLICIES
GUIDELINES
LATEST NEWS
China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin
Last:
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
Next:
China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection